Detection of multiresistant pathogens
[Multirezisztens kórokozók (MRK) kimutatása]
EPTIS Ringversuch Nr. 1258754 | Letze Änderung 2024-10-07 | URL: https://www.eptis.bam.de/pts1258754 https://www.eptis.bam.de/pts1258754
| Name des Anbieters | ||||||||||||||||||||||
| Name des Anbieters | QualiCont In Vitro Diagnostic Quality Control Nonprofit Ltd. QualiCont In Vitro Diagnostic Quality Control Nonprofit Ltd. | |||||||||||||||||||||
| Ansässig in | Hungary | |||||||||||||||||||||
| Sprache(n) | English, Hungarian | |||||||||||||||||||||
| Anmerkungen | Task: identification of test strains and determination of antibiotic resistance sensitivity. Interpretation of report towards the clinician, information about additional tasks. | |||||||||||||||||||||
| Klassifizierung | ||||||||||||||||||||||
| Produktgruppen | 
                    
                        Health care / medical devices
                         Human test material  | 
                |||||||||||||||||||||
| Prüfgebiete | 
                    
                        Medical analysis
                         | 
                |||||||||||||||||||||
| Technische Einzelheiten | ||||||||||||||||||||||
                        
  | 
                ||||||||||||||||||||||
| Ringversuchsziele | ||||||||||||||||||||||
| Zielgruppe des Ringversuchs | In vitro medical laboratories | |||||||||||||||||||||
| Relevante Rechtsvorschriften oder Normen | ILAC_G8:09/2019 – Guidelines on Decision Rules and Statements of Conformity ISO 15189 – Medical laboratories – Requirements for quality and competence ISO/TS20658:2017 – Medical laboratories – Requirements for collection, transport, receipt and handling of samples VIM3 – Vocabulaire International de Métrologie WHO – Guidance on regulations for the Transport of Infectious Substances | |||||||||||||||||||||
| Weitere Ziele | validation of testing methods | |||||||||||||||||||||
| Teilnehmerzahl | ||||||||||||||||||||||
| Anbieter unabhängig überprüft (akkreditiert, benannt, anerkannt) | 
                         Akkreditiert durch NAH (National Accreditation Authority) auf der Grundlage von ISO/IEC 17043:2010  | 
                |||||||||||||||||||||
| Die Durchführung des Ringversuchs ist in Auftrag gegeben durch | ||||||||||||||||||||||
| Kosten | ||||||||||||||||||||||
| Teilnahmegebühr | on demand | |||||||||||||||||||||
| Regelmässig durchgeführt | Ja (two times a year) | |||||||||||||||||||||
| Der Ringversuch wird durchgeführt seit | 2019 | |||||||||||||||||||||
| Kontaktdaten des Anbieters | ||||||||||||||||||||||
| Anbieter | Kontaktperson | |||||||||||||||||||||
| 
                        QualiCont In Vitro Diagnostic Quality Control Nonprofit Ltd.
                         Feketesas u. 19-21. I/7 6720 Szeged Hungary Telefon: +36 30 462 5864 Fax: Web: http://www.qualicont.com/qc/index_en.html http://www.qualicont.com/qc/index_en.html  | 
                    
                        Ms. Eszter Mezey
                         Telefon: +36 30 462 5864 Fax: E-Mail: mail@qualicont.com mail@qualicont.com  | 
                |||||||||||||||||||||